Yi Cheng, You Xiangyun, Sha Ang, Zhang Zhen, Yu Junfeng, Guo Xiaolin, Hu Henglong
Department of Urology, The First People's Hospital of Yichang, China Three Gorges University, Yichang, Hubei, China.
Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Front Oncol. 2023 Jan 16;12:1112343. doi: 10.3389/fonc.2022.1112343. eCollection 2022.
Patients after kidney transplantation have a much higher risk of developing malignant tumors than the general population. And the native kidney is an organ relatively susceptible to malignant tumors after renal transplantation. However, the simultaneous development of bilateral renal tumors is very rare; especially the bilateral native kidneys harbor different pathological types of renal cell carcinoma (RCC). We report a case of a patient who developed malignant tumors in both native kidneys nearly 19 years after renal transplantation. This patient underwent bilateral laparoscopic radical nephrectomy, and postoperative pathological examination showed clear cell RCC on the left native kidney and papillary RCC on the right one. And the early detection and surgical treatment resulted in a good prognosis. The literature related to the diagnosis and treatment of bilateral RCC after renal transplantation is also reviewed.
肾移植术后患者发生恶性肿瘤的风险比普通人群高得多。并且移植肾后的天然肾是一个相对易患恶性肿瘤的器官。然而,双侧肾肿瘤同时发生的情况非常罕见;尤其是双侧天然肾患有不同病理类型的肾细胞癌(RCC)。我们报告一例肾移植术后近19年双侧天然肾发生恶性肿瘤的患者。该患者接受了双侧腹腔镜根治性肾切除术,术后病理检查显示左侧天然肾为透明细胞RCC,右侧为乳头状RCC。早期发现和手术治疗带来了良好的预后。同时还对肾移植术后双侧RCC的诊断和治疗相关文献进行了综述。